Details for New Drug Application (NDA): 019591
✉ Email this page to a colleague
The generic ingredient in LARIAM is mefloquine hydrochloride. There are six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the mefloquine hydrochloride profile page.
Summary for 019591
Tradename: | LARIAM |
Applicant: | Roche |
Ingredient: | mefloquine hydrochloride |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 019591
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | May 2, 1989 | TE: | RLD: | Yes |
Expired US Patents for NDA 019591
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Roche | LARIAM | mefloquine hydrochloride | TABLET;ORAL | 019591-001 | May 2, 1989 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription